Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 7/20 | 0.53 |
| ▸ | NPY4R | P50391 | 7/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.53 |
| ▸ | NPY1R | P25929 | 5/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31415949 | 0.93 | SLC6A2 (0.63) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL38663397 | 0.93 | NPY2R (0.56) | SLC6A2NTSR2NTSR1SORT1NPY2R | |
| SCHEMBL31694376 | 0.87 | SLC6A2 (0.65) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL29418159 | 0.87 | SLC6A2 (0.64) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL32677402 | 0.86 | OPRM1 (0.61) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL29463750 | 0.86 | CALCR (0.57) | NTSR2NTSR1SORT1OPRM1NPY2R | |
| SCHEMBL32670304 | 0.85 | SLC6A2 (0.54) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL31307249 | 0.85 | SLC6A2 (0.66) | SLC6A2NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL29940473 | 0.85 | NTSR1 (0.64) | NTSR2NTSR1SORT1OPRM1NPY1R | |
| SCHEMBL31255817 | 0.84 | SLC6A2 (0.56) | SLC6A2NTSR2NTSR1SORT1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | claimed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | claimed |
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | disclosed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |
| EP-4484955-A1 | METHOD FOR SCREENING OF EXTRACELLULAR TISSUE PEPTIDES IN MAMMALIAN TISSUE SAMPLES FOR HEALTH STATUS EVALUATION, DISEASE DIAGNOSTICS AND NEOANTIGEN DISCOVERY | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |